Immunic Interest Income from 2010 to 2024

IMUX Stock  USD 1.20  0.06  5.26%   
Immunic Interest Income yearly trend continues to be fairly stable with very little volatility. Interest Income is likely to outpace its year average in 2024. Interest Income is income earned from the investment of cash or from lending money to others, including interest from bank accounts, bonds, or other interest-bearing investments. View All Fundamentals
 
Interest Income  
First Reported
2019-03-31
Previous Quarter
998 K
Current Value
776 K
Quarterly Volatility
408.1 K
 
Covid
Check Immunic financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Immunic's main balance sheet or income statement drivers, such as Depreciation And Amortization of 105.5 K, Interest Expense of 730.2 K or Other Operating Expenses of 54.8 M, as well as many indicators such as Price To Sales Ratio of 17.3 K, Dividend Yield of 0.0064 or PTB Ratio of 1.46. Immunic financial statements analysis is a perfect complement when working with Immunic Valuation or Volatility modules.
  
Check out the analysis of Immunic Correlation against competitors.
For more information on how to buy Immunic Stock please use our How to Invest in Immunic guide.

Latest Immunic's Interest Income Growth Pattern

Below is the plot of the Interest Income of Immunic over the last few years. It is income earned from the investment of cash or from lending money to others, including interest from bank accounts, bonds, or other interest-bearing investments. Immunic's Interest Income historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Immunic's overall financial position and show how it may be relating to other accounts over time.
Interest Income10 Years Trend
Slightly volatile
   Interest Income   
       Timeline  

Immunic Interest Income Regression Statistics

Arithmetic Mean625,250
Geometric Mean190,263
Coefficient Of Variation170.52
Mean Deviation732,500
Median66,000
Standard Deviation1,066,169
Sample Variance1.1T
Range3.2M
R-Value0.68
Mean Square Error653.4B
R-Squared0.47
Significance0.01
Slope162,783
Total Sum of Squares15.9T

Immunic Interest Income History

20243.2 M
20233.1 M
2022M
202166 K
2019107 K
2018521 K
2017650 K

Other Fundumenentals of Immunic

Immunic Interest Income component correlations

0.96-0.95-0.040.57-0.530.97-0.23-0.480.280.340.15-0.410.720.440.780.74-0.410.28
0.96-0.94-0.040.55-0.730.93-0.14-0.60.320.180.13-0.380.590.420.710.66-0.40.15
-0.95-0.940.03-0.680.56-0.980.340.49-0.36-0.36-0.240.25-0.61-0.28-0.68-0.70.2-0.17
-0.04-0.040.030.130.19-0.09-0.150.3-0.840.12-0.790.52-0.22-0.470.190.13-0.27-0.64
0.570.55-0.680.13-0.330.65-0.33-0.410.240.30.140.070.19-0.010.120.150.070.19
-0.53-0.730.560.19-0.33-0.52-0.160.79-0.380.36-0.060.25-0.07-0.27-0.17-0.10.250.07
0.970.93-0.98-0.090.65-0.52-0.35-0.450.380.40.28-0.320.710.340.70.73-0.210.3
-0.23-0.140.34-0.15-0.33-0.16-0.35-0.170.06-0.68-0.18-0.55-0.190.57-0.25-0.42-0.47-0.02
-0.48-0.60.490.3-0.410.79-0.45-0.17-0.450.3-0.120.340.06-0.320.00.120.27-0.11
0.280.32-0.36-0.840.24-0.380.380.06-0.45-0.080.87-0.450.250.45-0.070.010.340.55
0.340.18-0.360.120.30.360.4-0.680.3-0.080.320.070.50.010.450.570.250.32
0.150.13-0.24-0.790.14-0.060.28-0.18-0.120.870.32-0.340.360.38-0.030.120.590.67
-0.41-0.380.250.520.070.25-0.32-0.550.34-0.450.07-0.34-0.49-0.93-0.29-0.180.5-0.54
0.720.59-0.61-0.220.19-0.070.71-0.190.060.250.50.36-0.490.530.760.8-0.190.6
0.440.42-0.28-0.47-0.01-0.270.340.57-0.320.450.010.38-0.930.530.350.22-0.440.55
0.780.71-0.680.190.12-0.170.7-0.250.0-0.070.45-0.03-0.290.760.350.96-0.470.05
0.740.66-0.70.130.15-0.10.73-0.420.120.010.570.12-0.180.80.220.96-0.220.08
-0.41-0.40.2-0.270.070.25-0.21-0.470.270.340.250.590.5-0.19-0.44-0.47-0.220.15
0.280.15-0.17-0.640.190.070.3-0.02-0.110.550.320.67-0.540.60.550.050.080.15
Click cells to compare fundamentals

About Immunic Financial Statements

Immunic investors use historical fundamental indicators, such as Immunic's Interest Income, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Immunic. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Interest Income3.1 M3.2 M
Net Interest Income3.1 M3.2 M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for Immunic Stock Analysis

When running Immunic's price analysis, check to measure Immunic's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Immunic is operating at the current time. Most of Immunic's value examination focuses on studying past and present price action to predict the probability of Immunic's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Immunic's price. Additionally, you may evaluate how the addition of Immunic to your portfolios can decrease your overall portfolio volatility.